Filana Therapeutics (FLNA) Free Cash Flow (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Free Cash Flow of -$3.8 million for Q2 2026, up 22.78% year-over-year from -$3.1 million in Q2 2025, and up 56.93% quarter-over-quarter from -$8.9 million in Q1 2026.
Filana Therapeutics (FLNA) Free Cash Flow (2010 - 2026) Analysis & Trends
Filana Therapeutics' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$3.8 million for Q2 2026.
- In Q2 2026, Free Cash Flow rose 22.78% year-over-year to -$3.8 million; the TTM figure through Jun 2026 stood at -$29.3 million (up 69.43% YoY), while the FY2025 annual figure was -$32.9 million, up 71.9% from the prior year.
- Free Cash Flow for Q2 2026 stood at -$3.8 million, up from -$8.9 million in the prior quarter.
- The five-year high for Free Cash Flow was -$3.8 million in Q2 2026, with the low at -$61.3 million in Q4 2024.
- The 5-year median for Free Cash Flow is -$18.3 million (2024), against an average of -$18.1 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 938.81% in 2022, then surged 83.2% in 2025.
- Filana Therapeutics' Free Cash Flow stood at -$21.0 million in 2022, then decreased by 6.54% to -$22.4 million in 2023, then slumped by 174.12% to -$61.3 million in 2024, then soared by 83.2% to -$10.3 million in 2025, then surged by 62.78% to -$3.8 million in 2026.
- Business Quant data shows FLNA's Free Cash Flow at -$3.8 million in Q2 2026, -$8.9 million in Q1 2026, and -$10.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | -3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.83 Mn |
| Jun 30, 2026 | -3.83 Mn |
| Mar 31, 2026 | -8.90 Mn |
| Mar 31, 2026 | -8.90 Mn |
| Dec 31, 2025 | -10.30 Mn |
| Dec 31, 2025 | -10.30 Mn |
| Sep 30, 2025 | -6.28 Mn |
| Sep 30, 2025 | -6.28 Mn |
| Jun 30, 2025 | -4.96 Mn |
| Jun 30, 2025 | -4.96 Mn |
| Mar 31, 2025 | -11.34 Mn |
| Mar 31, 2025 | -11.34 Mn |
| Dec 31, 2024 | -61.29 Mn |
| Dec 31, 2024 | -61.29 Mn |
| Sep 30, 2024 | -18.32 Mn |
| Sep 30, 2024 | -18.32 Mn |
| Jun 30, 2024 | -18.30 Mn |
| Jun 30, 2024 | -18.30 Mn |
| Mar 31, 2024 | -19.13 Mn |
| Mar 31, 2024 | -19.13 Mn |